» Articles » PMID: 15654828

Phenotypic Perturbation of B Cells in the Wiskott-Aldrich Syndrome

Overview
Date 2005 Jan 19
PMID 15654828
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Wiskott-Aldrich syndrome (WAS) is an X-linked immunodeficiency/platelet disease due to mutations of WASP, a cytoskeletal regulatory protein of blood cells. Patients exhibit a range of immune defects generally attributed to defective T-cell function, including poor response to immunization, skewed immunoglobulin isotypes, eczema, recurrent infections, autoimmune disease and increased frequency of malignancies. Here we show a deficit of total B-cells in WAS patients of various ages and identify phenotypic perturbations involving complement receptors and CD27. Whereas B-cells of normal healthy donors are overwhelmingly CD21/CD35-positive, B-cells expressing these receptors are significantly reduced in number in WAS patients, and their paucity may cause suboptimal antigen capture and presentation. The frequencies of IgD(-) and IgG(+) patient B-cells were not different from healthy donors (although absolute numbers were decreased), indicating that isotype switching is occurring. In contrast, the frequency of cells positive for CD27, the marker of post germinal centre B-cells, was significantly decreased even among isotype-switched cells, and B-cells resembling germinal centre progenitors (CD10(+)CD27(-)CD38(bright)) were more frequent in adult patients, suggesting impaired germinal centre maturation/differentiation. The documentation of these phenotypic perturbations and deficit of total cells suggest that defects intrinsic to B-cells contribute to the impaired humoral immunity that characterizes this disease.

Citing Articles

Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.

Labrosse R, Chu J, Armant M, Everett J, Pellin D, Kareddy N Blood. 2023; 142(15):1281-1296.

PMID: 37478401 PMC: 10731922. DOI: 10.1182/blood.2022019117.


Common Variable Immunodeficiency and Autoimmune Diseases: A Retrospective Study of 95 Adult Patients in a Single Tertiary Care Center.

Mormile I, Punziano A, Riolo C, Granata F, Williams M, De Paulis A Front Immunol. 2021; 12:652487.

PMID: 34290696 PMC: 8287325. DOI: 10.3389/fimmu.2021.652487.


Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome.

Candotti F J Clin Immunol. 2017; 38(1):13-27.

PMID: 29086100 DOI: 10.1007/s10875-017-0453-z.


B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome.

Castiello M, Scaramuzza S, Pala F, Ferrua F, Uva P, Brigida I J Allergy Clin Immunol. 2015; 136(3):692-702.e2.

PMID: 25792466 PMC: 4559137. DOI: 10.1016/j.jaci.2015.01.035.


Next generation sequencing reveals skewing of the T and B cell receptor repertoires in patients with wiskott-Aldrich syndrome.

OConnell A, Volpi S, Dobbs K, Fiorini C, Tsitsikov E, de Boer H Front Immunol. 2014; 5:340.

PMID: 25101082 PMC: 4102881. DOI: 10.3389/fimmu.2014.00340.


References
1.
Zhang J, Shehabeldin A, da Cruz L, Butler J, Somani A, McGavin M . Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J Exp Med. 1999; 190(9):1329-42. PMC: 2195687. DOI: 10.1084/jem.190.9.1329. View

2.
Ochs H, Slichter S, Harker L, Von Behrens W, Clark R, Wedgwood R . The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood. 1980; 55(2):243-52. View

3.
Shcherbina A, Rosen F, Remold-ODonnell E . WASP levels in platelets and lymphocytes of wiskott-aldrich syndrome patients correlate with cell dysfunction. J Immunol. 1999; 163(11):6314-20. View

4.
Conley M, Notarangelo L, Etzioni A . Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999; 93(3):190-7. DOI: 10.1006/clim.1999.4799. View

5.
Agematsu K, Hokibara S, Nagumo H, Komiyama A . CD27: a memory B-cell marker. Immunol Today. 2000; 21(5):204-6. DOI: 10.1016/s0167-5699(00)01605-4. View